Drawing for Serial No. 90149486

USPTO serial 90149486

Serial No. 90149486

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BILLINGS, JOHN T
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 90149486?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ashly Boesche

Ashly Boesche Pattishall, McAuliffe, Newbury, Hilliard & Geralds200 S. Wacker Drive, Suite 2900Chicago, IL 60606UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Providing temporary use of non-downloadable computer software for tracking and taking inventory of pharmaceuticals, pharmaceutical preparations, and medical supplies, auditing medical records and medication dispensing systems, reporting data in medical records and medication dispensing systems, assessing and reviewing data in medical records and medication dispensing systems to formulate a discrepancy resolution process, implementing industry standards in connection with pharmaceuticals, pharmaceutical preparations, medical records, medication dispensing systems, and medical supplies, implementing industry standards in connection with tracking, dispensing, and taking inventory of pharmaceuticals, pharmaceutical preparations, and medical supplies, implementing industry standards in connection with tracking, auditing, assessing, reviewing, and reporting data in medical records and medication dispensing systems; Software as a service (SAAS) services featuring software for tracking and taking inventory of pharmaceuticals, pharmaceutical preparations, and medical supplies, auditing medical records and medication dispensing systems, reporting data in medical records and medication dispensing systems, assessing and reviewing data in medical records and medication dispensing systems to formulate a discrepancy resolution process, implementing industry standards in connection with pharmaceuticals, pharmaceutical preparations, medical records, medication dispensing systems, and medical supplies, implementing industry standards in connection with tracking, dispensing, and taking inventory of pharmaceuticals, pharmaceutical preparations, and medical supplies, implementing industry standards in connection with tracking, auditing, assessing, reviewing, and reporting data in medical records and medication dispensing systems; Providing authentication and verification services using computer hardware and software for pharmaceuticals, pharmaceutical preparations, medical dispensing systems, and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with pharmaceuticals, pharmaceutical preparations, medical records, medication dispensing systems, and medical supplies; tracking, auditing, assessing, reviewing, and reporting data found in medical records and medication dispensing systems; pharmaceuticals, pharmaceutical preparations, medical records, medication dispensing systems, and medical supplies; tracking and taking inventory of pharmaceuticals, pharmaceutical preparations, and medical supplies; auditing medical records and medication dispensing systems; reporting data in medical records and medication dispensing systems; assessing and reviewing data in medical records and medication dispensing systems to formulate a discrepancy resolution process; implementing industry standards in connection with pharmaceuticals, pharmaceutical preparations, medical records, medication dispensing systems, and medical supplies; implementing industry standards in connection with tracking, dispensing, and taking inventory of pharmaceuticals, pharmaceutical preparations, and medical supplies; implementing industry standards in connection with tracking, auditing, assessing, reviewing, and reporting data in medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards for tracking, dispensing, and taking inventory of pharmaceuticals, pharmaceutical preparations, and medical supplies; Testing, analysis, and evaluation of the goods of others to assure compliance with industry standards; Developing and maintaining a registry of approved identification numbers for use with an authentication and verification service for pharmaceuticals, pharmaceutical preparations, medication dispensing systems, and medical supplies; Creating and assigning identification numbers and radio frequency identification (RFID) tags for use with an authentication and verification service for pharmaceuticals, pharmaceutical preparations, medication dispensing systems, and medical suppliesACTIVE—
045Computer software licensingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 27, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 27, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 25, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 12, 2022ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Feb 7, 2022IUCNNOTICE OF ALLOWANCE CANCELLED—
Nov 12, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 12, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 12, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 3, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 3, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 3, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 3, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 3, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 25, 2021WOAGWITHDRAWAL OF ATTORNEY GRANTED—
Oct 25, 2021WOARTEAS WITHDRAWAL OF ATTORNEY RECEIVED—
Oct 22, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 22, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 22, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 18, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 30, 2021EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Aug 10, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 15, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 15, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 26, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 11, 2021PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 11, 2021ALIEASSIGNED TO LIE—
May 10, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 10, 2021ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
May 10, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 15, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 14, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 14, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 9, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 9, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 9, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 4, 2021DOCKASSIGNED TO EXAMINER—
Oct 6, 2020MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Oct 5, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 3, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance